About The Lancet Haematology
The Lancet Haematology launches in autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title is dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice. Building on The Lancet journals' reputation for publishing high-impact research, The Lancet Haematology is expected to attain the same standing and reputation in its discipline as its sister Lancet journals, and will maintain similar high reporting standards as all Lancet titles.
About our content
The journal publishes original research, unlinked and linked commentary, and correspondence related to previous content. The journal will cover the breadth of clinical haematology which includes, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine.
Fast Track publication
The Lancet Haematology offers a Fast Track peer-review service: for articles selected for review, we aim to have comments and provide a decision within 2–4 weeks of submission. Papers accepted for publication will receive the same expert editing and production services provided for all The Lancet titles, and are published online within 8 weeks of submission on average.
About the Editor
Dr Lan-Lan Smith is the founding Editor of The Lancet Haematology, and was a Senior Editor at The Lancet Oncology from 2011. Prior to joining The Lancet Oncology, she gained a PhD from Cancer Research UK/University College London, UK, and held research posts in the Haemato-Oncology Section at the Institute of Cancer Research, UK, and in the Department of Haematology-Oncology at King's College London, London, UK.
The Lancet Haematology投稿指南
The Lancet Haematology: Information for Authors
The Lancet Haematology is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice, including, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine. All original research judged eligible for consideration by the journal’s editors will be peer-reviewed within 72 h and, if accepted, published online within 8 weeks from submission. The journal will also publish relevant commentary and correspondence. Wherever possible, figures and good quality photographs (colour or black and white) should be used to supplement and to enhance the text. We also welcome videos. Further details on the different sections of The Lancet Haematology, and how to submit to the journal, are provided below. If you require further clarification, the journal's editorial staff will be pleased to help (email firstname.lastname@example.org).
Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. The Lancet journals are signatories of the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE Recommendations), and to the Committee on Publication Ethics (COPE) code of conduct for editors. We follow COPE's guidelines.
- Authors and contributors
- Conflicts of interest
- Role of the funding source
- Role of medical writer or editor
- Patients' consent and permission to publish
Download a PDF version of the full guidelines for authors of The Lancet Haematology.
The Lancet Haematology投稿地址
To submit a manuscript go to: http://ees.elsevier.com/thelancethaematology/